Overall, these studies suggest that genetics plays an important role in determining human longevity and that specific genes may be targeted to increase lifespan. However, further research is needed to fully understand the complex interplay between genetics and other factors that contribute to lifespan.And the risk of myocardial infarction. Engl. J Med. Ishikawa, S., Kario, Nago, N., Kayaba, Hiraoka, Matsuo, Goto, Miyamoto, Tsutsumi, Nakamura, ANeg ANCES, Shimada, MOAT S, Inoue, sees.K., Igarashi, _M., Factor VIL and hog reyes fibrinogen levels examined by SEX and other atherosclerotic risk factors in a Japanese population. The Jichi PA EES Medical School Cohort Thromb. Haemost. Ivanova, Henon, Iya, Lepage, Charron, Vicaut, Schachter. Factor VI alleles display dependent effects on survival and discriminate between individual land familial longevity. Hum. Mol. J Kalaria, Zareba, Moss, AS, Pancio, Marder, VS, Morrissey, JH., Weiss H., Sparks Greenberg HL, Dwyer E., Goldstein Watelet L.F., STAM EOIN Yh_ Gender-related differences in factors predicting recurrent cardiac events in patients after acute myocardial infarction. The investigators. Am. J Cardiol. Kervinen co-Savolainen oe Ea ASalokannel J Hynninen Heikkinen -Ehnholm Koistinen Kesaniemi Y.A., Apolipoprotein and polymorphisms longevity factors assessed in Indians. Atherosclero: //. Khoury MI., Flanders W.D., Non-traditional epidemiologic approaches in the analysis of gene-environment interaction: studies with controls! Am. eo Opp Epidemiol. Lane Green Scarabin P.Y., Nicaud .Bara Humphries Evans Luc Cambou Arveiler D., Cambien F., Factor VI polymorphism determines factor VIL activity in patients with myocardial infarction and control subjects in Belfast and France but it is not as strong an indicator of risk in the study. Atherosclero: //. Louhija, Miettinen, Kontula, Tikkanen, od eae_MJ., Miettinen T.A., sr, Tilvis, Aging and variation of plasma apolipoproteins. Relative loss of the apolipoprotein phenotype in centenarians. Thromb. Haemost. Macko, Kittner NS., Iy aes, Epstein A., Cox D.K., Wozniak Wityk RJ, Stern EB.S., Sloan MA, R,, Price T.R., Mies Depo., M arter RJ, Johnson CI., Earley CI., Meg NP AR TN ONO, Buchholz DW., Stolley PD., plasminogen activator antigen and stroke: The Stroke Prevention In Young Women Study. Martin, Genetics and the pathobiology of ageing. Philos. Trans. Soc. Lond. Biol. Meue M., Vaupel J_J.W., Holm Harvald, Longevity is moderately heritable in a sample of twins born FJ. Gerontol. DF #-DD Meade TW., Ruddock Stirling Y., Chakrabarti R., Miller .GJ., Fibrinolytic activity, clotting and long-term incidence of ischaemic heart disease in the Northwick OE LISD D OE Heart Study. Myant NB., Gallagher J, Barbir, Thompson .GR., Wile I, Humphries SE Restriction length polymorphisms in the apo I gene in relation to coronary artery Rey disease. JJ Nakata Katsuya Rakugi Takami Sato Kamide Ohishi Miki Higaki JT., Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E in Japanese population with cerebrovascular disease. Am. J Hypertens. PTOssei-Gerning, N., Wilson LI, Grant PS., Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb. Haemost. Paulweber, B., Friedl W., Krempler ON, Humphries SE., Sandhofer, Association of Hism at the apo # Mpa * gene locus with coronary heart disease and serum very low-density levels. Arteriosclerosis Piegorsch, W.W., Weinberg NAT CR., Taylor J, Non-hierarchical logistic models and case-only designs susceptibility in population-based studies. Stat. Med. Proust, JJ. mite owwp, Moulias, ee.R., Fumeron F., Bekkhoucha, Busson, Schmid, M., Hors, and evity. Tissue Antigens. AnkinenT., OO, Gagnon, Me MS, Perusse, L., Chagnon, Y.C., Rice, AS., Skinner, JS., Wilmore, J J.H., J DC., Bouchard - AGT and polymorphisms; exercise: blood pressure in Family Study. Am. J Physiol. Heart and Circ. Physiol. -JE: F = JD Rothman, KJ, ON OLDE INDE, Greenland, SE, EEF BO. Modern Epidemiology. 2nd ed. Lippincott-Raven, Philadelphia, PA. Saha, N., Tay, JS., A_ PS, I, Basair, JD NEE EE, Hong, SE. Restriction fragment length polymorphisms of the LPL and CETP genes and their influence on lipids and apolipoproteins in a healthy Chinese population. Hum. Genet. Scarabin, PY., Bonithon-Kopp, Bara, I, Malmejac/, Guize | , Samama /EE. Factor V Leiden and menopausal status. Thromb. Res. -J: --J -, D Scarabin, P.Y., Vissac AM., Kirzin JM., Bourgeat A., Amiral _, Agher | , Guize | , EEE Myant! N.B., Gallagher J, Barbir | , Thompson GR., Wile I Humphries SEFE. Restriction fragment length polymorphisms of the SOD1 gene in relation to coronary artery disease. Modern Epidemiology. 2nd ed. Lippincott-Raven Philadelphia PA. Saha N1 Tay JS1 A_2 PS1 I Basair JD NEE EE7 Hong SE7 Procoagulant-anticoagulant balance during hormone replacement therapy? A randomized fact NN IEEE placebo-controlled study. Thromb Haemost. F, -E, D Vaupel JJ.W., Manton, KG., Stallard, .E., EJE. The effect of heterogeneity in individual frailty on the dynamics of mortality. Demography / DED Vaupel, SW., Jouee ashin, oer AL, EF Pe NRHeterogeneitys - some surprising effects of selection on population dynamics. Am. JEJ = ang, Khoury, M., EEJ. Evolving methods in genetic epidemiology. IIL. Gene-environment interaction in stepwise epidemiologic research. Epidemiol. Rev. / D Yashin, AL, Vaupel, J.J.W., Andreev, IKF., Tan Fe, lachine | LA, Carotenuto | , Benedictis | , Bonafe ! Valensin, sep Ney eeee a Franceschi C., EEF ND. Combining genetic and demographic information in population studies of aging and longevity. J Epidemiol Biostatistics / -FE -ED Co ashin eee AL, Mowry eee- Benedictis | ,G." Vaupel OS J.W.", Tan NS AN , Andreev | . KF., Iachine | LA | , Bonafe! , Duca | , Valensin _S., Carotenuto MPN nn ss. Franceschi - Genes, demography and life - the contribution of demographic data in genetic studies on aging and longevity. NED ES. Am. Hum. Genet. //JF //E,(cid:  ) Yashin AL,_Tachine| LA